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Cardiovascular diseases represent the leading cause of death in developed countries.
Modern surgical methods show poor efficiency in the substitution of small-diameter
arteries (<6 mm). Due to the difference in mechanical properties between the native
artery and the substitute, the behavior of the vessel wall is a major cause of inefficient
substitutions. The use of decellularized scaffolds has shown optimal prospects in
different applications for regenerative medicine. The purpose of this work was to
obtain polylysine-enriched vascular substitutes, derived from decellularized porcine
femoral and carotid arteries. Polylysine acts as a matrix cross-linker, increasing the
mechanical resistance of the scaffold with respect to decellularized vessels, without
altering the native biocompatibility and hemocompatibility properties. The biological
characterization showed an excellent biocompatibility, while mechanical tests displayed
that the Young’s modulus of the polylysine-enriched matrix was comparable to native
vessel. Burst pressure test demonstrated strengthening of the polylysine-enriched
matrix, which can resist to higher pressures with respect to native vessel. Mechanical
analyses also show that polylysine-enriched vessels presented minimal degradation
compared to native. Concerning hemocompatibility, the performed analyses show that
polylysine-enriched matrices increase coagulation time, with respect to commercial
Dacron vascular substitutes. Based on these findings, polylysine-enriched decellularized
vessels resulted in a promising approach for vascular substitution.
Keywords: decellularized vessels, vascular substitutes, polylysine, surface grafting, matrix degradation
INTRODUCTION
Main cause of death worldwide is represented by cardiovascular diseases (Zoghbi et al., 2014),
with a predicted annual incidence of cardiovascular disease-related mortalities expected to increase
to 23.3 million worldwide by 2030 (Mathers and Loncar, 2006). These diseases are characterized
by partial or complete occlusion of blood vessels lumen, leading to reduced blood flow and
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subsequent tissue damage and necrosis (Pashneh-Tala et al.,
2015). The most common cardiovascular diseases are coronary
heart diseases, cerebrovascular diseases, peripheral artery
diseases, and deep vein thrombosis. When blood flow is
significantly altered, leading to potential cardiovascular risks for
patients, surgical intervention is required with the substitution
of damaged vessels (Abdulhannan et al., 2012). In order to
replace or bypass a damaged or occluded vessel, vascular grafts
were introduced (Pashneh-Tala et al., 2015). Currently, the
gold standard for vascular grafting are autologous arteries or
veins, because of their natural biocompatibility, their non-
thrombogenicity and their adequate mechanical characteristics
(Farkouh et al., 2012). While arteries, such as the internal thoracic
artery or radial artery, ensure a superior patency (Athanasiou
et al., 2011; Masden et al., 2012), the saphenous vein is the
most used autograft vessel (Harskamp et al., 2013). The use of
saphenous veins is preferred because of the limited availability
of adequately healthy arteries and the possible complications
associated with arteries’ removal. On the other hand, autologous
saphenous veins also show some drawbacks, such as their limited
availability, due to the fact that the vessel could show poor
quality, and its harvest could lead to damage or infection in the
surgery site (Klinkert et al., 2004; Conte, 2013). Also, differences
with the native vessel in compliance and elasticity often entail
substitute’s occlusion, caused by atherosclerosis and cellular
infiltration (Harskamp et al., 2013).
Another option for vascular surgery is the use of synthetic
vascular grafts. Materials used for these grafts are mainly
polymers, such as polyethylene terephthalate (PET and Dacron)
and expanded polytetrafluoroethylene (ePTFE and Gore-Tex).
Synthetic grafts used in large-caliber arteries (>8 mm), have
demonstrated good results, such as in aortoiliac substitutes,
where patency is shown to be around 90% (Faries et al., 2000) and
in medium-caliber arteries (6–8 mm), such as carotid or common
femoral artery replacements (Burger et al., 2000). Nevertheless,
in small-caliber vessels (<6 mm) the use of synthetic grafts is
limited due to poor success rates, thus in these cases autologous
vessels are surely preferred. Small diameter grafts experience
low and turbulent blood flow (Kannan et al., 2005), due to
compliance differences between the synthetic substitute and
native vessel at the graft site (Seifalian et al., 2003). Synthetic
graft poor mechanical properties, added with no endothelial
layer formation and poor hemocompatibility properties, lead
to thrombus formation and luminal occlusion due to intimal
hyperplasia, which explain poor patency rates of small-caliber
synthetic grafts (Lemson et al., 2000; Kannan et al., 2005).
Moreover, reduced circulation due to narrowing of peripheral
grafts adds further challenges in maintaining adequate circulatory
conditions (Couto et al., 2015; Amuzescu et al., 2016).
Due to the increasing demand for vessel substitution in
severe arterial disease, and the fact that, for the reasons
mentioned above, often the autologous graft is not possible, a
biocompatible small-caliber vascular graft is required for surgical
graft. Development of small-caliber vascular grafts must take into
account several properties. The graft must be resilient and feature
mechanical strength comparable to native vessels, with a burst
pressure of ≥2.25 Bar (Seifu et al., 2013) to prevent aneurysm
formation, and possessing comparable compliance with respect
to native vessels, in order to avert intimal hyperplasia (Xue and
Greisler, 2003). Also, luminal surfaces must allow the formation
of a new endothelial layer, that will mediate vascular hemostasis
(Seifalian et al., 2003). When established, the endothelium not
only guarantees a perfect hemocompatibility, but also retains
vessel integrity, directing the adjacent cell behavior via several
signaling mechanisms. Indeed, in damaged endothelium the
signaling loss is the main factor that leads to smooth muscle
cell hyperproliferation, resulting in intimal hyperplasia and vessel
occlusion, finally leading to graft failure (Jeschke et al., 1999;
Melchiorri et al., 2013).
The use of decellularized biological matrices in regenerative
medicine exploits the structure and mechanical properties
of natural extracellular matrix (ECM) without yielding
immunological reactions due to its biological origin.
Decellularization process implies the removal of cellular
residues from the tissue that could trigger antigenic reactions.
Decellularization can be conducted with biological and/or
chemical agents, such as enzymes, chelating agents, combinations
of acids and bases, combinations of hypotonic and hypertonic
solutions, detergents, solvents, in combination with physical
agents such as agitation, pressure, and abrasion (Boccafoschi
et al., 2017; Lin et al., 2018).
Preservation of the ECM also allows to preserve tissues’
mechanical properties (Conklin et al., 2002; Cho et al.,
2005). Several clinical products obtained from human or
animal decellularized tissues are commercially available for
various applications, such as dermal replacement, soft tissue
regeneration, as well as ophthalmic, orthopedic, and dentistry
uses (Crapo et al., 2011).
Differently from synthetic grafts, decellularized matrices
supply the appropriate environment for allowing cell
repopulation, growth and differentiation. On the other hand,
decellularized matrices present some altered mechanical
properties, in terms of weakening of the vessel wall (Williams
et al., 2009). This feature may eventually lead to implant failure,
due to aneurysm formation and disturbances in the blood
flow. One of the aims of regenerative medicine is to perform
decellularization techniques that yield vascular grafts with
mechanical characteristics of native vessels and positive immune
properties of autologous vessels (Moroni and Mirabella, 2014).
Taking these considerations into account, the aim of the
present study is to obtain a decellularized matrix, derived
from femoral and carotid porcine arteries, and enrich it
with polylysine, in order to strengthen the vessel wall while
maintaining adequate biocompatibility of the scaffold.
MATERIALS AND METHODS
Decellularization Process
Porcine femoral and carotid arteries, provided by Life and Device
S.r.l. (Turin, Italy), have been decellularized with a three-step
protocol. In summary, the vessels have been treated with a 1 M
NaCl, 8 mM CHAPS and 25 mM EDTA solution for 1 h at 37◦C
under stirring. After prolonged PBS rinsing, the matrices have
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been incubated with a second solution of 1 M NaCl, 1.8 mM SDS
and 25 mM EDTA for 1 h at 37◦C under stirring. Finally, in order
to remove the residual DNA content, samples have been treated
with a solution of 6.4 µM Deoxyribonuclease I from bovine
pancreas, 0.1 M MgCl2, and 0.9 M NaCl, and stirred for 16 h
at room temperature (all reagents Sigma-Aldrich, United States).
Decellularized vessels have been stored at−20◦C before use.
Functionalization of the Decellularized
Biologic Tissue (sueGraft R© Process)
Decellularized matrices have been enriched with 1 mg/ml
polylysine (Sigma-Aldrich, United States). The process
(sueGraft R©) used was optimized by TissueGraft S.r.l., all
details are owned by the company.
To evaluate the efficiency of the enriching process, three
different matrices were compared:
(1) Native vessel.
(2) Decellularized matrix.
(3) Polylysine grafting: decellularized matrix subjected to the
enrichment process.
Evaluation of the Decellularization
Procedure
In order to verify the efficiency of the decellularization process,
several analyses were performed (Wolf et al., 2012), including
histology to evaluate the absence of cellular material using
4′, 6′-diamidino-2-phenylindole dihydrochloride (DAPI) and
hematoxylin and eosin (H&E) staining. For the nuclear staining
analysis (DAPI), samples were fixed in a 4% formaldehyde
solution, then rinsed in PBS and soaked in DAPI solution
(300 nM for 2 min). After an additional PBS rinsing, samples were
observed under a fluorescence microscope.
For H&E staining, samples were fixed in 4% formaldehyde
solution, dehydrated and paraffin embedded. Samples were
then cut into sections of 5 µm, rehydrated and soaked in
hematoxylin for 15 min. Following this, eosin solution (0.05%
eosin in distilled water and acetic acid) was applied for 1 min.
Finally, samples were dehydrated and observed with an optic
microscope (Leica DM2500, Leica, Germany). Samples images
have been acquired through a Leica DFC7000 T camera (Leica,
Germany) and analyzed with Leica Application Suite X software
(Leica, Germany).
In addition, the amount of DNA in each sample was also
quantified through a DNA quantification assay. Native and
decellularized vessel slices (5 mm × 5 mm) were lyophilized
and digested for 16 h at 55◦C in a buffer solution, containing
100 µg/ml proteinase K, 75 mM NaCl, 25 mM EDTA, 1%
SDS, pH = 8. Samples were incubated with a 6 M NaCl
solution for 30 min and centrifuged at 15,000 rpm; followed
by 1 ml of isopropanol. In order to precipitate the DNA
after centrifugation, the supernatant was removed, and 70%
ethanol added. After evaporation of ethanol, 20 µl of ultrapure
water was added and the amount of DNA measured with full-
spectrum UV-visible measurements (NanoDrop 2000, Thermo
Fisher Scientific, United States).
Finally, agarose gel electrophoresis was used to visualize
the DNA fragmentation. Briefly, 50 ng of DNA from native
and decellularized samples were mixed with EZ-Vision loading
buffer (VWR, Italy), and loaded on a 1% agarose gel. After the
electrophoresis, DNA was visualized with ChemiDoc Imaging
System (Bio-Rad, Italy).
Enrichment Process Assessment and
Morphological Analysis
X-Ray Photoelectron Spectroscopy (XPS)
X-ray Photoelectron Spectroscopy (XPS) analysis was conducted
with a PerkinElmer PHI 5600 ESCA system. The instrument
is supplied with a dual Al (monochromatic) and Mg anode
operating at 10 kV and 200 W. The diameter of the analyzed spot
was about 500 µm, the sampling depth was 5–8 nm, and the base
pressure 10−8 Pa. The angle between the electron analyzer and
the sample surface was 45 degrees.
After preliminary evaluation using the monochromated X-ray
source, spectra were acquired using the non-monochromated
Mg anode, given side-effects due to charging were much lower.
Analysis was conducted acquiring wide range survey spectra (0–
1,000 eV binding energy) and detailed high-resolution peaks of
relevant elements.
Quantification of elements was completed using the software
and sensitivity factors furnished by the manufacturer.
Attenuated Total Reflectance Infra-Red Spectroscopy
(ATR-IR)
ATR-IR spectra were obtained using a Nicolet iS10 ATR-IR
spectrometer with a diamond crystal (Thermo Fisher Scientific,
United States). Samples were placed on the crystal and held
steady by the specific crimping tool. The experimental set up
involved acquisition of 32 scans in the range 500–4000 cm−1,
both of sample and background, at a resolution of 4 cm−1
with the sampling depth is approximately 1.6 µm. Beside
decellularized and polylysine-enriched samples, the ATR-IR
spectrum of polylysine (Sigma-Aldrich, United States) was
acquired as a reference.
Confocal Microscopy
The microscopy visualization of the structures was completed
using a Leica TCS SP8 DLS (Digital LightSheet, CLF, Harwell,
United Kingdom) system with image acquisition technical
information as shown in Table 1. The focus of this tool was
the observation of the scaffold collagen structures under static
conditions. Samples were not stained but fixed in situ with agar
to immobilize the sample during the test.
Micro Computed Tomography (Micro-CT)
A micro-CT system (High Flux Nikon XTEK Bay), Manchester
X-ray Imaging Facility (MXIF) was used to non-destructively
image and visualize the three-dimensional micro-morphology
as previously described (Metscher, 2009; Disney et al., 2017).
Staining method used was 1% (w/v) phosphotungstic acid,
H3PW12O40 (PTA) in water for 40 h followed by washing in 70%
ethanol and dried for 48 h at room temperature.
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TABLE 1 | Technical data of Figure 3A images.
A B C D
Field of view 1471.52 µm × 1471.52 µm 1471.52 µm × 1471.52 µm 735.76 µm × 735.76 µm 735.76 µm × 735.76 µm
Number of spaced
steps
127 steps spaced of 6 µm 212 steps spaced of 6 µm 394 steps spaced of 1.5 µm, 342 steps spaced of 1.5 µm
Illumination laser 405 nm 405 nm 405 nm 405 nm
Laser power 25 µW 25 µW 25 µW 25 µW
Exposure time per
plane
600 ms 600 ms 300 ms 600 ms
Bandpass detection
filter
504–545 nm 504–545 nm 504–545 nm 504–545 nm
Detection objective HC PL FLUOTAR 5×/0.15 IMM HC PL FLUOTAR 5×/0.15 IMM HC APO L 10×/0.30 WATER HC APO L 10×/0.30 WATER
Illumination objective
for light sheet creation
1.6×/0.05 DRY 1.6×/0.05 DRY HC PL FLUOTAR 2.5×/0.07 DRY HC PL FLUOTAR 2.5×/0.07 DRY
Samples were mounted on a stage within the imaging
system and subsequently scanned at a voltage of 100 kV
and a current of 50–100 mA. Specimens were scanned at a
2 µm resolution with an integration time of 1,000–1400 ms to
produce 3D images. Raw 2D images were thresholded to remove
background values (threshold value = 60) and further analyzed
using Avizo software (Thermo Fisher Scientific, United States)
(Walton et al., 2015).
Mechanical Test
Mechanical properties of native and decellularized enriched
matrices were tested. The Young’s modulus and tensile
strength of the different samples was measured, briefly, Young’s
moduli were quantified from the stress-strain curve obtained
with the Instron 5564 (Instron Corporation, Norwood, MA,
United States). System control and data analyses were performed
using Instron R© BluehillTM 3 material-testing software (Instron
Corporation, Norwood, MA, United States). Sample dimensions
(length, width, and thickness) were measured in order to
normalize the mechanical test parameters. Uniaxial tests were
performed at room temperature and with a tension rate of
0.5 mm∗s−1.
Burst pressure was also measured. The test was performed
using a hydraulic press, a high-precision digital pressure gauge
and a PBS solution as a liquid. The sample was stressed by
pushing the PBS until bursting, thus detecting the maximum
operating pressure in laboratory conditions.
Mechanical properties were also evaluated after simulation of
physiological conditions (dynamic condition test). Decellularized
and polylysine-enriched vessels have been inserted in a circuit,
composed of a peristaltic pump (Masterflex L/S, Cole-Parmer
Instrument Company, United States), 10 mm diameter tubing
(Cole-Parmer Instrument Company, United States), and a
chamber containing the samples and filled with the PBS.
Fluid speed was 15 ml∗min−1 and samples were tested
for up to 30 days. Samples were weighed before and
after the dynamic test in order to evaluate the samples’
weight loss after dynamic conditions were applied. Finally,
both Instron and burst pressure tests, were performed after
dynamic conditions.
Cell Viability Assay
Cell viability of human umbilical vein endothelial cells EA.hy926
(ATCC R© CRL-2922TM), cultured on decellularized and enriched
matrices, was assessed. Cells were cultured with Dulbecco’s
Modified Eagle’s Medium (DMEM – Euroclone, Italy) enriched
with 10% fetal bovine serum (FBS), 2 mM glutamine and
100 U∗mL−1 penicillin (Euroclone, Italy). Endothelial cells were
cultured at 5∗104 cells∗cm−2. In order to evaluate cell viability,
after 1, 3, and 7 days of culture, a MTS assay (CellTiter 96 R©
AQueous Non-Radioactive Cell Proliferation Assay, Promega,
Italy) was performed. Briefly, a 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
solution was added to each sample for 3 h. Absorbance
was measured by UV-VIS spectrophotometry (Victor X4,
PerkinElmer, United Kingdom), at a wavelength of 490 nm.
Measures were proportional to cell viability.
In order to evaluate cell adhesion and proliferation, EA.hy926
cells were cultured on decellularized and polylysine enriched
matrices for 3 and 7 days. Matrices were then observed through
Hematoxylin-eosin staining, as described in Section “Evaluation
of the Decellularization Procedure.”
Cell adhesion was evaluated after simulation of physiological
conditions (dynamic condition test). EA.hy926 were cultured on
the lumen side of decellularized and polylysine-enriched vessels
for 24 h. Afterward, samples were inserted in a circuit, composed
of a peristaltic pump (Masterflex L/S, Cole-Parmer Instrument
Company, United States), 10 mm diameter tubing (Cole-Parmer
Instrument Company, United States), and a chamber containing
the vessels samples and filled with DMEM enriched with 10%
FBS. Fluid speed was 15 ml∗min−1 and samples were tested
for up to 3 days.
Monocyte Activation
Monocyte viability and inflammatory response elicited by
decellularized and polylysine-enriched matrices was evaluated.
After 24 h, cell viability on samples was evaluated with MTT
assay. Briefly, culture medium was replaced with a 5 mg/ml
solution of Thiazolyl Blue Tetrazolium Blue (MTT, Sigma-
Aldrich, Italy) in RPMI 1640 and incubated for 4 h at 37◦C.
Medium was removed and DMSO was added, in order to
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dissolve formazan salts. Absorbance was measured by UV-VIS
spectrophotometry (Victor X4, PerkinElmer, United Kingdom),
at a wavelength of 570 nm. Absorbance is proportional
to cell viability.
To evaluate the effect of decellularized and enriched samples
on monocytes activity and polarization, cells on samples and
controls (M0, M1, and M2) were seeded with 2∗105 cells∗cm−2.
Differentiation of monocytes in control samples was obtained
adding 10% FBS-enriched RPMI 1640 medium (Euroclone, Italy)
with human (hr)GM-CSF (50 ng·mL−1, Sigma-Aldrich, Italy), to
induce M1 macrophages polarization, and in 10% FBS-enriched
medium containing hrM-CSF (50 ng·mL−1 Sigma-Aldrich, Italy)
to induce M2 macrophages polarization. These conditions have
been maintained for 7 days.
After 7 days, culture medium from each sample was
collected and TNF-α release was evaluated through ELISA assay
(RAB0476, Sigma Aldrich, Italy). Analysis was performed
according to manufacturer’s instructions. Absorbance
was measured by UV-VIS spectrophotometry (Victor X4,
PerkinElmer, United Kingdom), at a wavelength of 450 nm.
Measures were proportional to TNF-α concentration.
Hemocompatibility
Thromboelastography (TEG) is a technique that measures
several parameters relative to blood coagulation by evaluating
the viscoelastic properties of blood from the beginning of
coagulation to the clot rupture with fibrinolysis. Particularly
important parameters are the coagulation formation, its
progression, maximum strength, and stability, which provides
important information on coagulation, fibrinolysis, and platelet
functionality. Blood samples were collected in Vacutainer
(BD, United States) containing sodium citrate and tested at
37◦C. Blood was exposed to the control graft (Dacron R©), the
decellularized scaffold and the enriched scaffold for 30 min and
subsequently analyzed using Thromboelastograph R© (TEG R© 5000
Thrombelastograph R© Hemostasis Analyzer System) and the
Kaolin TEG standard protocol. Briefly, after 30 min 1 ml of blood
was collected and placed in a vial containing kaolin. After few
seconds, 340 µl of blood were sampled in the thrombelastograph
with 20 µl of calcium chloride, in order to eliminate the
anticoagulant effect of sodium citrate. Coagulation parameters
were evaluated through thromboelastogram obtained at the end
of the testing time.
RESULTS
Decellularization Process Efficiency
In order to evaluate the efficiency of the decellularization
protocol, DAPI staining was performed on native and
decellularized tissue. Figure 1 shows the native tissue and
the presence of cellular nuclei in native tissues while, after
the decellularization treatment, however, no nuclei were
present. H&E histology results confirmed the preservation
of the extracellular matrix microstructure within the
decellularized samples. No cellular nuclei could be detected
in the decellularized tissue samples.
DNA quantification on native and decellularized tissues
strengthened the previous results, indicating a successful DNA
removal from the matrix. In contrast to native tissue, which
contained 860 ± 300 ng DNA per mg wet weight (n = 3),
decellularized tissues showed a significant decrease of DNA
content to 15± 11 ng DNA per mg wet weight (n = 3). Agarose gel
showed that no DNA strands longer than 100 bp were available
on decellularized samples, while in native samples the DNA
presence was verified.
Enrichment Process Efficiency and
Morphological Analysis
Samples were analyzed, as shown in Figures 2A,B, the survey
spectra of decellularized and polylysine-enriched samples show
differences, with the obtained surface composition reported in
Table 2. Decellularized scaffolds showed peaks due to carbon,
oxygen and silicon, and just a very weak signal from nitrogen.
XPS tests just the outermost molecular layers of materials (the
sampling depth is about 5–8 nm), and the obtained data likely
reflects surface side-effects due to processing. Silicone is a
common contaminant of surfaces and the peak of Si is a common
finding in surface analysis of biological samples. There was also
a lower than expected N/C and N/O ratio, which was probably
due to processing aids (see also discussion of ATR-IR results)
remaining on or combined with the sample surface. In contrast,
the XPS spectrum of polylysine-enriched samples showed a
strong peak due to nitrogen. Hence, the sample surface showed
being enriched with a nitrogen-containing compound, clearly
supporting the presence of polylysine. Further information was
provided by ATR-IR analysis, as reported in the next section.
ATR-IR analysis of decellularized (red), polylysine-enriched
(blue), and reference polylysine (green) in the amide band region
of the IR spectrum (Figure 2C). The sampling depth of ATR-
IR, using a diamond crystal, is around 1.6 mm, that is this
technique is less surface-sensitive than XPS. All samples show
the typical spectral features due to amide bonds, as expected.
Concerning differences between tested samples, the Amide II
band at about 1,550 cm−1 shifts toward lower wavenumbers
from decellularized to polylysine-enriched (arrow), centering
close to the Amide II band of the polylysine reference. Also,
around 1,400 cm−1 the shape of the band (arrow) changes
from decellularized to polylysine. Taken together, XPS and
ATR-IR results strongly suggest that successful enrichment
with polylysine of the decellularized sample is obtained
through this process.
In Figure 3A the structure of decellularized and polylysine-
enriched matrices are shown through confocal microscopy. The
polylysine-enriched sample shows a structure of fractures better
defined than in the decellularized sample, and the roughness is
narrower than the latter. In general, the enriched sample shows
more vertical oriented fractures, while in decellularized the lines
are not so straight composing soft curves. The images suggest
that the enrichment treatment changes the micro and macro
collagen structure, orientating and bridging collagen fibers, as
can be seen in Figure 3B, which confirms the data obtained
from confocal microscopy. Indeed, decellularized sample’s tissue
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FIGURE 1 | Decellularization of porcine artery showing (A) DAPI and HandE histology before and after decellularization process. (B) Quantitative determination of
DNA in a native and decellularized matrix. Data are expressed as mean values ± SD (n = 3, *p ≤ 0.05). (C) Agarose gel electrophoresis of DNA derived from native
and decellularized matrices. The image is representative of three different analyses.
FIGURE 2 | X-ray photoelectron spectroscopy (XPS) spectra of (A) decellularized and (B) polylysine enriched matrices. (C) AT-IR spectra of decellularized (red),
polylysine enriched matrices (blue), and Polylysine as a control (green).
seems thinner and hollower with respect to both native and
polylysine enriched matrix. The thickness and the wall microfiber
structure of polylysine enriched matrix seems adequately similar,
suggesting that the fiber reorganizing after enrichment process
leads to a structure comparable to native sample.
Mechanical Test
Young’s Modulus, Tensile Strength and Burst
Pressure Results: Static Conditions
To characterize the mechanical properties (Figures 4A,B)
specimens were tested, using an Instron instrument, and strained
until specimen failure.
The Young’s modulus is directly related to the compliance of
the material. Decellularized samples present a significant Young’s
modulus decrease when compared with native and polylysine
sample values. On the other hand, the tensile strength of the
polylysine enriched matrix is increased, compared to the native
vessel, while the same parameter between the decellularized
matrix is lower with respect to the other samples.
The figure shows that, with respect to the native control,
elasticity is not affected. The Young’s modulus of the enriched
matrix is shown to be not significantly different to the native
vessel. The scaffold wall is strengthened after enrichment.
TABLE 2 | Surface composition (atomic%) of tested samples (n = 3).
Sample O N C Si
Decellularized 17.1 1.4 68.4 13.1
Polylysine 16.7 11.3 72.0 –
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FIGURE 3 | (A) Confocal microscopy of decellularized and polylysine-enriched vessels. (B) Micro-CT analysis of native vessel, decellularized and polylysine-enriched
matrices.
Young’s Modulus, Tensile Strength and Burst
Pressure Results: Dynamic Conditions
Samples were tested for up to 30 days under dynamic conditions,
with a PBS flow inside the vessel lumen. After performing
dynamic tests, matrix degradation was measured. All the samples
reveal a weight loss: native samples’ mass decreases of 60%, while
decellularized samples roughly 55%. Nevertheless, the polylysine
samples present only a 28% weight loss, with an evident matrix
preservation compared to other samples (Figure 4C).
Burst pressure was measured before and after applying
dynamic conditions. Native artery pressure is 1.3 bar, while
with polylysine treatment, the value is considerably increased,
rising to 3.2 bar.
After 30 days, the maximum pressure value supported by the
samples decreases by 40% in the native sample and only a 13% in
the sample treated with polylysine (Figure 4D).
The successful performances of polylysine enriched matrices
are confirmed by the evaluation of matrix degradation in terms
of tensile strength loss. Indeed, after 10 days polylysine enriched
matrices lose only 5% of tensile strength while, decellularized
matrix is 17% weaker than the static control. The differences are
more evident after 20 days where decellularized matrices lose 26%
of tensile strength, while treated decellularized vessels showed
similar performances with respect to 10-day samples (Figure 4E).
Cell Viability Assay: Static and Dynamic
Conditions
Endothelial cells were seeded in the vessels lumen and cell
proliferation rate was measured after 1, 3, and 7 days. Figure 5A
shows comparable cell proliferation rates for decellularized
and polylysine-enriched samples after 7 days. Endothelial
cells’ adhesion and proliferation were also evaluated, using
hematoxylin-eosin and DAPI staining. Results show that after
3 days, cells adhered on both decellularized and polylysine-
enriched samples, while after 7 days of culture cells formed
an almost continuous monolayer only on polylysine-enriched
surfaces (Figure 5B). Finally, cell adhesion was evaluated after
3 days of dynamic conditions (Figure 5C). DAPI staining shows
almost no cell nuclei on decellularized samples, indicating that
cells do not remain adherent to that matrices. On the other hand,
polylysine-enriched samples show cell nuclei almost forming a
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FIGURE 4 | Mechanical testing results under static conditions: (A, left panel) Young’s modulus and tensile strength representation for native, decellularized and
polylysine grafting. Data are expressed normalized with a native vessel. The data origin is the stress–strain curves. Data are expressed as mean values ± SD (n = 3,
∗p ≤ 0.05). (B) Burst pressure data for native, decellularized and polylysine grafting. Data are expressed as mean values ± SD (n = 3, ∗p ≤ 0.05). Mechanical testing
results under dynamic conditions: (C) Burst pressure data for native, decellularized, and polylysine grafting for static and dynamic conditions. Data are expressed as
mean values ± SD (n = 5, ∗p ≤ 0.05). (D) Degradation assays in terms of weight loss. Data are expressed as mean values ± SD (n = 5, ∗p ≤ 0.05). (E) Degradation
assays in terms of tensile strength loss. Data are expressed as mean values ± SD (n = 3, ∗p ≤ 0.05).
continuous monolayer, suggesting that cell adhesion is optimized
on enriched matrices.
Monocyte Activation
Monocyte viability on decellularized and enriched matrices
was evaluated after 24 h after seeding. After 24 h, results
show viable monocytes growth on control, decellularized and
enriched matrices. Monocytes in contact with decellularized
and enriched matrices showed an excellent viability. Thus,
we proceeded analyzing monocytes polarization after
7 days of culture. Adequate media were used to induce
macrophages polarization in M1 and M2, and used as
control with respect to results obtained on macrophages
growth on decellularized and enriched samples. As shown in
Figure 6, M1 control released a significant amount of TNF-α,
expressing an inflammatory phenotype, as expected. All the
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FIGURE 5 | (A) Endothelial cells viability assays. MTS test was performed after 1, 3, and 7 days. Data are expressed as mean values ± SD (n = 3, ∗p ≤ 0.05).
(B) Hematoxylin-Eosin staining of decellularized and polylysine enriched matrices with cells cultured for 3 and 7 days. (C) DAPI staining of decellularized and
polylysine enriched matrices after dynamic conditions.
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FIGURE 6 | (A) Monocyte viability assay. MTT assay was performed after
24 h. (B) ELISA assay on TNF-α concentration after 7 days of culture. Data
are expressed as mean values ± SD (n = 3, *p ≤ 0.05).
other conditions, both in M0 and M2 controls, as well as
on decellularized and enriched matrices, TNF-a release is not
significant, confirming the absence of inflammatory environment
(Figure 6).
Hemocompatibility Test
We evaluated the materials’ hemocompatibility using
thromboelastography (TEG). Among the coagulation
parameters, reaction time (R) indicates the time required to
induce the clot formation. The matrices treated with polylysine
have a significantly increased R-value with respect to Dacron
and decellularized matrices. Fibrinogenic activity is rather
decreased on enriched matrices, as a result the clot strength is
lower than both matrices used as reference. The coagulation time
parameter is directly correlated with the required time for the
clot formation, in order to reach the maximum strength value
before starting the dissolution process. This value increases in
the samples treated with polylysine reflecting a benefit in terms
of functionality. In addition, platelet aggregation confirms the
lower rate in the clot formation process (Figure 7).
These results clearly indicate a favorable influence on
coagulation parameters in the presence of polylysine enrichment
in terms of hemocompatibility.
DISCUSSION
Although autologous arterial and venous grafts are the gold
standard as bypass graft material, due to insufficient length or
quality of native vessels for roughly 40% of patients requiring
arterial bypass surgery autologous grafts are not available
(Moroni and Mirabella, 2014).
Synthetic grafts, including Dacron and ePTFE, which
efficiently work for large-diameter vascular grafts, have
shown disappointing clinical results in small-diameter artery
reconstruction, due to thrombotic complications when compared
to venous bypasses (Klinkert et al., 2004). For these reasons,
decellularized scaffolds were introduced. The ECM is an optimal
substrate in terms of biological performances, because ECM
is able to drive cell adhesion, proliferation, and differentiation
(Barnes et al., 2011); in this way, unlike synthetic materials,
decellularized substitutes are able to solve a complex problem
as the repopulation with different cell types, as showed by
Pellegata et al. (2013). On the other hand, decellularized
matrices progressively lose the suitable mechanical properties
needed for tissue replacement (Williams et al., 2009; Xiong
et al., 2013). In the present study, we exploited the properties
of the decellularized matrices, strengthened with polylysine
enrichment, to prevent wall weakening (Gu et al., 2018).
Polylysine is a polymer that has been widely used in tissue
engineering, as a cell adhesion promoter, because of strong
positive charge (Wang et al., 2018; Zhang et al., 2019) and as a
biomaterial strengthener (Collin et al., 2004; Wang et al., 2016).
Evaluation of the effectiveness of decellularization process
showed that no cell nuclei are present in decellularized matrices,
and the DNA quantity is significantly lower than the native
vessel, as well as also being lower than the gold standard defined
by literature (Gilbert et al., 2009). However, it is unclear if
the DNA left in decellularized matrices could elicit a biological
response from the host (Keane et al., 2012). Several commercial
products derived from decellularized matrices with positive
clinical outcomes contain DNA fragments, for this reason the
probability that residual DNA could induce a host response is low
(Pellegata et al., 2013; Gu et al., 2018).
In order to predict the possible outcome of a vascular
substitution, mechanical properties are a crucial parameter to
evaluate. In particular, graft failure occurs when the substitute’s
compliance is different from the native vessel (Xue and Greisler,
2003). Although Young modulus and failure strength of these
substitutes are not significantly different from native vessels,
the compliance was not taken into account as a key factor
(Bergmeister et al., 2005; Ketchedjian et al., 2005; Mahara et al.,
2015). On the contrary, Xue and Greisler (2003) showed that,
in human patients graft failure occurs when the substitute’s
compliance is different from the native vessel hyperplasia. For
this reason, in the present study differences in compliance
between polylysine-enriched substitute and the native vessel were
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FIGURE 7 | Haemocompatibility test. Coagulation parameters (A: reaction time; B: coagulation time; C: platelet aggregation; D: fibrinogenic activity) were evaluated
on synthetic vascular substitutes (DACRON) and treated matrices. Data are expressed as mean values ± SD (n = 3 from different healthy donors, ∗p ≤ 0.05).
evaluated. As known from literature, compliance is also related
to wall stiffness (Baltgaile, 2012), which can be evaluated by
Young’s modulus. Mechanical characterization of the matrices in
static conditions showed that polylysine enriched matrix showed
increased wall strength, while Young’s modulus is similar to
native vessels. The assessment of mechanical properties shows
that, given the similarities in stiffness between native vessel and
polylysine enriched matrices, the compliance is comparable.
In order to assess the durability of the enrichment and the
behavior of the substitute under dynamic conditions, degradation
rates were also evaluated, as weight loss and tensile strength
loss. In both cases, polylysine enriched vessels showed the best
behavior, retaining matrix and mechanical properties, while
all the other matrices considered lose their properties after
30 days. The importance of mechanical properties evaluation is
underlined in Williams et al. (2009) who study the differences in
stiffness between fresh and decellularized rabbit carotid arteries;
also Mahara et al. (2015) focus on difference in stress strain
curve between original tissue and peptide-enriched decellularized
ostrich carotid artery graft; finally, López-Ruiz et al. (2017)
evaluate tensile strength, maximum load and burst pressure of
native, decellularized and coated porcine carotid arteries.
Treated matrix cytocompatibility showed to be adequate,
compared to decellularized matrices, indicating a favorable
environment for efficient repopulation by the host vascular
cells. The adequacy of modified decellularized matrices was
also demonstrated by Mahara et al. (2015) who indicate
adequate cell repopulation of peptide-enriched decellularized
grafts in porcine model; also Boerboom et al. (2002) confirmed
good recellularization of decellularized carotid artery implant;
finally Hilbert et al. (2004) further evidentiates successful
repopulation of decellularized carotid goat graft. Moreover,
treated matrices seem to favor recruitment of monocytes,
while not inducing inflammatory phenotype expression. Further
analyses will focus on macrophages polarization, in order
to verify the potentiality of this matrices to induce a
regenerative response more than an inflammatory response.
In fact, this aspect is important because it is demonstrated
that a positive immune system response contributes to the
implant success (Hibino et al., 2015). Hemocompatibility tests
displayed that polylysine enriched matrices develop blood
clots slower and with less strength with respect to both
decellularized matrices and Dacron, a synthetic polymer widely
used in vascular substitution. Furthermore, coagulation assays
indicate that polylysine enriched matrices could help to
avoid thrombosis, another drawback of synthetic substitute
(Fukunishi et al., 2016).
Given the positive results obtained by these in vitro
experiments, these polylysine enriched substitutes are under
preclinical evaluation using ovine models.
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CONCLUSION
Overall, our tests confirm the efficiency of both decellularization
and enrichment methods, as well as the ability of polylysine
enriched matrices to maintain adequate mechanical properties,
while enhancing cell adhesion and proliferation. Thus, the
enriched biological substitutes could represent an innovative
approach for application in vascular tissue engineering.
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